Biodesix (BDSX) Gains from Sales and Divestitures (2022 - 2026)
Biodesix (BDSX) reported Gains from Sales and Divestitures of $35000.0 for Q1 2026, up 45.83% on a YoY basis from $24000.0 in Q1 2025, and down 5.41% quarter-over-quarter from $37000.0 in Q4 2025.
Biodesix (BDSX) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends
Biodesix has reported Gains from Sales and Divestitures for 5 years, with the latest figure at $35000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 45.83% year-over-year to $35000.0; the trailing twelve-month figure through Mar 2026 stood at $35000.0 (up 45.83% YoY), and the FY2025 full-year result was $37000.0, up 23.33% from the prior year.
- Gains from Sales and Divestitures for Q1 2026 stood at $35000.0, down from $37000.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $710000.0 in Q4 2023, with the low at $2000.0 in Q3 2024.
- Historically, Gains from Sales and Divestitures has averaged $136562.5 across 5 years, with a median of $36000.0 in 2025.
- Annual changes were most pronounced in 2024 — Gains from Sales and Divestitures tumbled 98.48% — and 2025, when it surged 1650.0%.
- Biodesix's Gains from Sales and Divestitures stood at $357000.0 in 2022, then soared by 98.88% to $710000.0 in 2023, then slumped by 95.77% to $30000.0 in 2024, then increased by 23.33% to $37000.0 in 2025, then retreated by 5.41% to $35000.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $35000.0 (Q1 2026), $37000.0 (Q4 2025), and $35000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Biodesix | 146.77 Mn | 121.20 Mn | 21.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 710,000.00 |
| Dec 31, 2023 | 710,000.00 |